Protara Therapeutics Prices $75 Million Public Offering

Kirkland & Ellis LLP has advised Protara Therapeutics, Inc. Mintz has advised the underwriters. Protara Therapeutics, Inc., a clinical-stage company focused on transformative therapies for cancer…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here